Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...
Satralizumab is safe and effective for patients with myelin oligodendrocyte glycoprotein antibody-associated disease, the new ...
A remote culinary medicine program combining cooking and health coaching leads to an average weight loss of more than 4% at 1 ...
Scaling vision correction across the global textile and garment sector was estimated to generate $27B in incremental annual ...
Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...
The Well News on MSN
Clinical trial tested high-dose vitamin D for COVID with mixed results
WASHINGTON - Long COVID remains one of the more stubborn medical puzzles of the past several years. Millions of people who ...
Treatment with GMRx2, a single pill combination of three low-dose blood pressure medicines, significantly reduced the risk of ...
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...
Regulatory milestones include EMA approval in 2024 and FDA approval in 2025 for chronic hand eczema, addressing limitations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results